Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MINT Venture Partners is a global venture platform founded in 2020 by Dr. Jae-Hoon Song, MD, PhD, with a focus on biotech and healthcare innovation. Headquartered in Seoul, South Korea, the firm also operates a subsidiary in Singapore, MINTBUS PTE. LTD. MINT combines discovery, incubation, acceleration, and investment into a cohesive model aimed at creating impactful businesses in the healthcare sector.
The firm has established itself as a key player in the biotech landscape, particularly in the Asia-Pacific region. MINT's approach includes a diverse portfolio of innovative projects and structured programs designed to support startups at various stages of development. Their commitment to advancing medical technologies is evident in their partnerships with visionary founders and industry experts.
MINT Venture Partners invests primarily in the biotech and healthcare sectors, targeting innovative technologies that advance medicine. Their investment strategy encompasses multiple stages, including pre-seed, seed, seed+, Series A, and growth equity. MINT emphasizes drug and treatment development, focusing on small molecules, antibody therapies, cell and gene therapies, and medical devices for diseases such as cancer and neurological disorders.
Additionally, MINT supports diagnostic development, particularly in genomic and proteomic analysis, AI solutions, and point-of-care testing. The firm also collaborates with startups in digital healthcare, enhancing accessibility and patient-centered approaches. Their structured programs, such as PRISM and CUBE, facilitate startup creation and growth acceleration, ensuring comprehensive support for emerging companies.
MINT Venture Partners has a diverse portfolio that includes ten notable companies, each contributing to advancements in biotech and healthcare:
Dr. Jae-Hoon Song, MD, PhD - Founder, Chairman & CEO. Dr. Song has extensive experience in the biotech sector and leads MINT's strategic vision.
Seong Min Park - Chief Financial Officer. Park oversees financial operations and strategy, bringing expertise from previous roles in finance.
Yong Soo Jeong - Chief Investment Officer. Jeong is responsible for investment strategies and portfolio management, with a strong background in venture capital.
Kay M. Kim - Chief Intellectual Property Officer. Kim is a patent attorney with significant experience in intellectual property management in biotech.
Yoohwan Choi - Chief Business Development Officer. Choi focuses on strategic partnerships and business growth initiatives.
Swan Sohn, MBA - Chief Commercial Officer. Sohn manages commercial strategies and market entry for portfolio companies.
Jiwon Park, PhD - Director, Investment. Park leads investment analysis and due diligence processes.
Hong Hoi Gu, MD, PhD - Mint MD Senior Advisor. Gu provides medical expertise and guidance for healthcare-related investments.
Kyoung Sil Lee, MD - Mint MD Advisor. Lee offers insights into clinical applications and healthcare innovations.
Brandon Song, BA - Senior Manager, Business Development. Song supports business development efforts across the portfolio.
Lynn Cho, MBA - Senior Manager, Business Development/Investment. Cho assists in investment strategies and business development initiatives.
To pitch MINT Venture Partners, founders should use the contact form available on their website at mintventures.bio. The pitch deck should include a comprehensive overview of the business model, market analysis, and team qualifications. MINT prefers detailed information on the technology and its potential impact on the healthcare sector.
Response times can vary, but founders should expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
MINT Venture Partners runs several programs designed to support startups in the biotech and healthcare sectors:
In June 2021, MINT Venture Partners participated in a $55 million Series B extension for Senda Biosciences, a company focused on microbiome-based therapeutics. This investment highlights MINT's commitment to advancing innovative healthcare solutions.
Recently, MINT has been actively building and accelerating biotech and healthcare startups through its structured programs, further solidifying its presence in the industry.
What are MINT Venture Partners' investment criteria?
MINT focuses on biotech and healthcare startups that demonstrate innovative technologies and solutions. They invest across various stages, from pre-seed to growth equity, emphasizing drug discovery, diagnostics, and digital healthcare.
How can founders pitch to MINT Venture Partners?
Founders can pitch their startups through the MINT Venture Partners website at mintventures.bio. They should include a detailed business plan, market analysis, and information on the team and technology.
What makes MINT Venture Partners different from other investors?
MINT operates as an integrated venture studio, combining investment with incubation and acceleration programs. This unique model allows them to provide comprehensive support to startups, from concept to commercialization.
What is the geographic focus of MINT Venture Partners?
MINT operates globally, with a particular emphasis on the Asian market, especially South Korea and Singapore. They actively engage in the Korea-Singapore biotech corridor.
What kind of post-investment support does MINT provide?
MINT Venture Partners offers extensive post-investment support through specialized programs for drug discovery, incubation, and acceleration. Their network of industry professionals aids startups in scaling operations effectively.
What is the typical check size for investments made by MINT?
While specific check sizes are not disclosed, MINT invests across various stages, indicating flexibility in funding amounts based on the startup's needs and growth potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.